Man Group’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Man Group's CDNA Position: Q2 2026 in Review
Man Group reduced its CareDx (CDNA) stake by 24% in Q2 2026, selling an estimated $860K and leaving 126,962 shares worth $3.62M. The position accounts for 0.01% of the portfolio, ranked #1284.
Man Group first reported a position in CDNA in Q4 2019 and has held it in 19 quarters since. The position peaked at $4.39M in Q4 2025. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Man Group held 126,962 shares of CareDx worth $3.62M as of Q2 2026.
- Man Group sold 39,512 CareDx shares in Q2 2026, an estimated $860K.
- CareDx made up 0.01% of Man Group's portfolio in Q2 2026, its #1284 holding.
- Man Group first reported a position in CareDx in Q4 2019 and has held it in 19 quarters since.
- Man Group's CareDx position peaked at $4.39M in Q4 2025.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.